Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients

医学 HBeAg 恩替卡韦 内科学 胃肠病学 复归 危险系数 乙型肝炎表面抗原 入射(几何) 累积发病率 替诺福韦 乙型肝炎病毒 免疫学 病毒 拉米夫定 人类免疫缺陷病毒(HIV) 置信区间 生物 队列 表型 物理 光学 基因 生物化学
作者
Yi–Cheng Chen,Chao‐Wei Hsu,Rong‐Nan Chien
出处
期刊:Journal of Medical Virology [Wiley]
卷期号:95 (11)
标识
DOI:10.1002/jmv.29213
摘要

Abstract A complete investigation of the clinical outcomes after treatment cessation in HBeAg‐positive patients with HBeAg loss is limited. We retrospectively recruited 242 HBeAg‐positive patients with HBeAg loss after a median duration of 37.2 months with tenofovir (TDF, n = 77) or entecavir (ETV, n = 165) treatment. There were 77 (31.8%) patients with sustained virological remission (SVR), 85 (35.1%) with HBeAg‐reversion virological relapse, 80 (33.1%) with HBeAg‐negative virological relapse after treatment cessation, and 23 (9.5%) with HBsAg loss. Clinical data at baseline, on‐treatment and during off‐treatment follow‐up were analyzed. The 3‐year cumulative incidences of overall, HBeAg‐reversion and HBeAg‐negative virological relapse were 70.2%, 54%, and 53.5%, respectively. The common factors associated with HBeAg‐reversion and HBeAg‐negative virological relapse were tenofovir treatment (hazard ratio [HR] = 5.411, p < 0.001; HR = 2.066, p = 0.006, respectively) and HBsAg at end of treatment (EOT) (HR = 1.461, p = 0.001; HR = 1.303, p = 0.019, respectively). The 5‐year cumulative incidence of HBsAg loss in SVR patients was 13.7% and EOT HBsAg was the only associated factor (HR = 0.524, p = 0.024). Compared to that of ETV‐treated patients, TDF‐treated patients had a significantly higher 3‐year cumulative incidence of virological relapse (87.3% vs. 62.8%, p < 0.001), earlier HBeAg‐reversion virological relapse (2.9 vs. 7.8 months, p < 0.001), a higher rate of HBeAg‐reversion virological relapse (53.2% vs. 26.7%) and a lower SVR rate (15.6% vs. 39.4%) ( p < 0.001). In summary, the clinical outcomes after treatment cessation in HBeAg‐positive patients with HBeAg loss were composed of HBeAg‐reversion virological relapse, HBeAg‐negative virological relapse and SVR. TDF was significantly associated with off‐treatment virological relapse. EOT HBsAg plays an important role in HBsAg loss among SVR patients and posttreatment virological relapse.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hyominhsu发布了新的文献求助10
刚刚
科研鬼才完成签到 ,获得积分10
刚刚
1秒前
LiAlan发布了新的文献求助10
1秒前
刘畅发布了新的文献求助10
1秒前
852应助迷人的学术妲己采纳,获得10
1秒前
lichee完成签到,获得积分10
1秒前
夏晴晴发布了新的文献求助30
2秒前
wbgwudi完成签到,获得积分10
2秒前
顾矜应助SHUIw采纳,获得10
2秒前
天天快乐应助蔫蔫采纳,获得10
3秒前
ddsyg126发布了新的文献求助10
3秒前
XinZhang关注了科研通微信公众号
3秒前
3秒前
NexusExplorer应助一漾采纳,获得10
4秒前
Archer发布了新的文献求助30
5秒前
青山完成签到,获得积分10
5秒前
不想发布了新的文献求助10
5秒前
枫叶完成签到 ,获得积分10
6秒前
脑洞疼应助DYQin采纳,获得10
6秒前
6秒前
北有云烟完成签到 ,获得积分10
6秒前
丘比特应助文静采纳,获得10
7秒前
专注的问筠完成签到,获得积分10
8秒前
8秒前
orixero应助Zeus采纳,获得50
8秒前
111111111发布了新的文献求助10
8秒前
共享精神应助PengHu采纳,获得10
8秒前
哈牛发布了新的文献求助10
8秒前
river_121完成签到,获得积分10
9秒前
9秒前
徐大头发布了新的文献求助10
9秒前
代纤绮完成签到,获得积分10
9秒前
鲜艳的访风完成签到,获得积分10
9秒前
10秒前
10秒前
qianhua发布了新的文献求助10
11秒前
jichups完成签到,获得积分10
11秒前
小蘑菇应助jmy1995采纳,获得10
11秒前
刘欣完成签到,获得积分10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969060
求助须知:如何正确求助?哪些是违规求助? 3513962
关于积分的说明 11171223
捐赠科研通 3249302
什么是DOI,文献DOI怎么找? 1794772
邀请新用户注册赠送积分活动 875377
科研通“疑难数据库(出版商)”最低求助积分说明 804769